Hangzhou, China

Yubin Lv

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Other. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yubin Lv. Retrieved from https://idiyas.com/inventor/yubin-lv-h1zo0lrx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yubin Lv: Innovator in Bruton's Tyrosine Kinase Inhibitors

Introduction

Yubin Lv is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of Bruton's tyrosine kinase (BTK) inhibitors. His innovative work has the potential to impact various therapeutic areas.

Latest Patents

Yubin Lv holds 1 patent related to Bruton's tyrosine kinase inhibitors. The patent details specific formulas, referred to as Formula (I) and Formula (II), which are crucial for the development of these inhibitors. This invention represents a significant advancement in targeted therapies.

Career Highlights

Throughout his career, Yubin has worked with various organizations, including Hangzhou Bangshun Pharmaceutical Co., Ltd. His expertise in the pharmaceutical industry has allowed him to focus on developing innovative treatments that address unmet medical needs.

Collaborations

Yubin has collaborated with notable colleagues, including Xibin Liao and Jianming Yin. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Yubin Lv's contributions to the field of Bruton's tyrosine kinase inhibitors highlight his role as an innovative inventor. His work continues to pave the way for advancements in targeted therapies, showcasing the importance of research and collaboration in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…